PhaseRx, Inc.
PZRXQ
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -40.34% | -87.31% | 133.68% | 201.70% | 322.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.22% | -66.16% | 85.19% | 94.52% | 110.18% |
| Operating Income | 19.22% | 66.16% | -85.19% | -94.52% | -110.18% |
| Income Before Tax | 17.74% | 68.07% | -84.65% | -53.78% | -71.52% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 17.74% | 68.07% | -84.65% | -53.78% | -71.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.74% | 68.07% | -84.65% | -53.78% | -71.52% |
| EBIT | 19.22% | 66.16% | -85.19% | -94.52% | -110.18% |
| EBITDA | 19.26% | 66.27% | -89.67% | -99.32% | -116.62% |
| EPS Basic | 17.76% | 83.58% | 91.58% | 92.98% | 92.21% |
| Normalized Basic EPS | 17.74% | 83.58% | 91.58% | 92.98% | 92.21% |
| EPS Diluted | 17.76% | 83.58% | 91.58% | 92.98% | 92.21% |
| Normalized Diluted EPS | 17.74% | 83.58% | 91.58% | 92.98% | 92.21% |
| Average Basic Shares Outstanding | 0.00% | 94.41% | 2,093.25% | 2,089.14% | 2,101.51% |
| Average Diluted Shares Outstanding | 0.00% | 94.41% | 2,093.25% | 2,089.14% | 2,101.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |